CMPS vs SLN: stock comparison and AI forecast
Compass Pathways Plc (CMPS) and Silence Therapeutics Plc (SLN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CMPS Compass Pathways Plc
- Price
- $7.81 -16.8% · 6M
- Market Cap
- $1.08B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SLN Silence Therapeutics Plc
- Price
- $19.72 +167.9% · 6M
- Market Cap
- $1.19B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- SLN is 1.1 times larger than CMPS by market capitalization ($1.19B against $1.08B).
- Over the last six months SLN returned +167.9% and CMPS -16.8%.
- CMPS carries 2.65 times debt per unit of equity, against 1.77 times for SLN.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CMPS | SLN |
|---|---|---|
| Market Cap | $1.08B | $1.19B |
| P/B Ratio | 7.61x | 30.93x |
| EPS | $-3.83 | $-0.53 |
| Book Value/Share | $1.03 | $0.64 |
| Revenue/Share | – | $0.01 |
| FCF/Share | – | $-0.70 |
Profitability & Margins
| Metric | CMPS | SLN |
|---|---|---|
| ROE | -187.4% | – |
| ROA | -51.3% | – |
| ROIC | -102.3% | -72.9% |
| Gross Margin | – | 69.8% |
| Operating Margin | – | -9023.4% |
| EBT Margin | – | -7919.6% |
| Tax Rate | 1.3% | 0.0% |
Financial Health
| Metric | CMPS | SLN |
|---|---|---|
| Current Ratio | 1.50x | 7.42x |
| D/E Ratio | 2.65x | 1.77x |
| Financial Leverage | 3.65x | 2.77x |
| Interest Coverage | -35.3x | – |
| Working Capital | $162M | $82M |
Cash Flow
| Metric | CMPS | SLN |
|---|---|---|
| Operating Cash Flow | -$177M | -$42M |
| Free Cash Flow | – | -$42M |
| Capital Spending | – | $0.00M |
| FCF/Sales | – | -5583.4% |
| CapEx/Sales | – | 0.4% |
Operational Efficiency
| Metric | CMPS | SLN |
|---|---|---|
| Asset Turnover | – | 0.01x |
| Fixed Assets Turnover | – | 0.6x |
Income Statement
| Metric | CMPS | SLN |
|---|---|---|
| Total Revenue | – | $760K |
| Operating Income | -$198M | -$68M |
| Net Income | -$266M | – |
| R&D Expense | $109M | $48M |
| Cost of Goods Sold | – | $90K |
Dividend & Shareholder Information
| Metric | CMPS | SLN |
|---|---|---|
| Shares Outstanding | 138M | 60M |
| EPS Growth | -100.7% | – |
CMPS vs SLN: stock comparison and AI forecast
Which is bigger, CMPS or SLN?
SLN is 1.1 times larger than CMPS by market capitalization ($1.19B against $1.08B).
Which stock performed better over the last six months, CMPS or SLN?
Over the last six months SLN returned +167.9% and CMPS -16.8%.
Which one does Intratio's AI model rank higher, CMPS or SLN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.